Whether patients haven't yet reached their weight loss goals on lower-dose Wegovy injectables, or they simply have a more significant amount of weight to lose, the 21% weight loss demonstrated in the STEP UP trial, if all patients stayed on treatment, shows what's possible with this new dose, and that's an opportunity we're excited to provide," said Ed Cinca, senior vice president, Marketing & Patient Solutions at Novo Nordisk
I already have thyroid problems,'" Clarkson said
Muchos pacientes mantienen una dosis menor despus de alcanzar su peso objetivo
If GLP-1 drugs are so expensive, why is Medicare expanding access
She thought she was doing what GLP-1 ads said to do: taking care of herself
Use of them does not imply any affiliation with or endorsement by them.